| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 09/23/2010 | US20100240674 Use of compounds derived from benzamidine methanesulphonate or a pharmaceutically acceptable salt thereof, for example imatinib mesylate, for the preparation o f a drug for the treatment of neurodegenerative niemann-pick c disease (npc) |
| 09/23/2010 | US20100240659 Nitrogen-containing heterocyclic derivative having 11ss-hydroxysteroid dehydrogenase type i inhibitory activity |
| 09/23/2010 | US20100240653 Biphenyl sulfonyl and phenyl-heteroaryl sulfonyl modulators of the histamine h3-receptor useful for the treatment of disorders related thereto |
| 09/23/2010 | US20100240650 Substituted pyrrolines as kinase inhibitors |
| 09/23/2010 | US20100240649 Quinazoline and quinoline derivatives as irreversible protein tyrosine kinase inhibitors |
| 09/23/2010 | US20100240646 Pyrrolo-triazine aniline compounds useful as kinase inhibitors |
| 09/23/2010 | US20100240642 1H-Indole-2-Carboxylic Acid Derivatives Useful As PPAR Modulators |
| 09/23/2010 | US20100240641 Aldosterone Synthase and/or 11B-hydroxylase Inhibitors |
| 09/23/2010 | US20100240634 Fluorene Compound and Pharmaceutical Use Thereof |
| 09/23/2010 | US20100240632 Drug for improving hyperglycemia |
| 09/23/2010 | US20100240627 Composition and methods relating to glucocorticoid receptor-alpha and peroxisome proliferator-activated receptors |
| 09/23/2010 | US20100240616 Novel lipid compounds |
| 09/23/2010 | US20100240611 Methods for preparing dpp-iv inhibitor compounds |
| 09/23/2010 | US20100240603 Expression inhibitor of nuclear transcription factor ap-1 and pharmaceuticals and products using the same |
| 09/23/2010 | US20100240587 Stable formulations of amylin and its analogues |
| 09/23/2010 | US20100240586 Peg modified exendin or exendin analog and compositions and use thereof |
| 09/23/2010 | US20100240581 Selective proteasome inhibitors for treating diabetes |
| 09/23/2010 | US20100240580 Azoloarine derivatives, method for the production thereof, pharmaceuticals containing these compounds and the use thereof |
| 09/23/2010 | US20100239687 Uses of rare earth elements for slimming |
| 09/23/2010 | US20100239686 Method For Making Nanolipidic Particles |
| 09/23/2010 | US20100239669 Combinations of statins and anti-obesity agent |
| 09/23/2010 | US20100239660 Product and use of omega-3s matching human tissue ratios for treatment of inflammatory and other conditions |
| 09/23/2010 | US20100239603 Combinations of Botanical Extracts for Promoting Cardiovascular Health |
| 09/23/2010 | US20100239589 Methods and Compositions for Ameliorating Diabetes and Symptoms Thereof |
| 09/23/2010 | US20100239558 Lipid Hydrolysis Therapy for Atherosclerosis and Related Diseases |
| 09/23/2010 | US20100239554 Extended recombinant polypeptides and compositions comprising same |
| 09/23/2010 | US20100239552 Combination Therapies for Treating Metabolic Disorders |
| 09/23/2010 | US20100239530 Ifnar2 mutants, their production and use |
| 09/23/2010 | US20100239523 Tlr modulators and methods for using the same |
| 09/23/2010 | US20100239520 Organic compounds |
| 09/23/2010 | DE102009013642A1 Substituierte Phenylalaninderivate und deren Verwendung Substituted phenylalanine derivatives and the use thereof |
| 09/23/2010 | CA2755969A1 Modulators of cystic fibrosis transmembrane conductance regulator |
| 09/23/2010 | CA2755639A1 Polyunsaturated fatty acid synthase nucleic acid molecules and polypeptides, compositions, and methods of making and uses thereof |
| 09/23/2010 | CA2755253A1 Bicyclic compounds as inhibitors of diacylglycerol acyltransferase |
| 09/23/2010 | CA2755251A1 Bicyclic compounds as inhibitors of diacylglycerol acyltransferase |
| 09/23/2010 | CA2755072A1 Combination therapies for treating metabolic disorders |
| 09/23/2010 | CA2755069A1 Anti-inflammatory and antioxidant conjugates useful for treating metabolic disorders |
| 09/23/2010 | CA2749650A1 Piperidine derivatives as nk3 receptor antagonists |
| 09/22/2010 | EP2230241A1 Tetrahydro-imidazoý1,5-a¨pyrazine derivatives, preparation methods and medical uses thereof |
| 09/22/2010 | EP2229955A1 Fibroblast growth factor receptor-1 inhibitors and methods of treatment using the same |
| 09/22/2010 | EP2229952A1 Plasma anti-diabetic NUCB2 peptide (pladin and nesfatin-1n) and uses thereof |
| 09/22/2010 | EP2229948A1 Mesenchymal CD34- stem cells for use in diabetes gene therapy |
| 09/22/2010 | EP2229939A1 Capsule formulation |
| 09/22/2010 | EP2229374A1 Amido-thiophene compounds and their use as 11-beta-hsd1 inhibitors |
| 09/22/2010 | EP2229373A1 Substituted 2-naphthoic acids as antagonists of gpr105 activity |
| 09/22/2010 | EP2229368A1 Cyclic urea inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
| 09/22/2010 | EP2229362A1 Piperazines as anti-obesity agents |
| 09/22/2010 | EP2229356A1 1,2-disubstituted-4-benzylamino-pyrrolidine derivatives as cetp inhibitors useful for the treatment of diseases such as hyperli pidemia or arteriosclerosis |
| 09/22/2010 | EP2229164A1 Elevation of the plasma hdl-cholesterol level |
| 09/22/2010 | EP2134704B1 Compounds and compositions as modulators of gpr119 activity |
| 09/22/2010 | EP1809271B9 Use of (r)-(halobenzyloxy) benzylamino-propanamides as sodium and/or calcium channel selective modulators |
| 09/22/2010 | EP1692114B1 Novel benzimidazole and imidazopyridine derivatives and use thereof as a medicament |
| 09/22/2010 | EP1599464B1 Novel cyclic urea derivatives, preparation method thereof and pharmaceutical use of same as kinase inhibitors |
| 09/22/2010 | EP1401853B1 Modulators of pharmacological agents |
| 09/22/2010 | CN201585758U Therapeutic massage mat adopting traditional Chinese medicine magnetotherapy |
| 09/22/2010 | CN1970015B Enzymatic extraction method of pawpaw polyphenol |
| 09/22/2010 | CN1947722B Blood sugar regulator used during user having meals and its preparation method |
| 09/22/2010 | CN1943719B A Chinese traditional medicinal composition for treating diabetes and its preparation method |
| 09/22/2010 | CN1943713B A Chinese traditional medicinal composition for treating diabetes and its preparation method |
| 09/22/2010 | CN1863799B Chroman carboxylic acid derivatives for the treatment of diabetes and lipid disorders |
| 09/22/2010 | CN1612746B Use of HEPCIDIN as a regulator of iron homeostasis |
| 09/22/2010 | CN101842106A Novel use of processed ginseng |
| 09/22/2010 | CN101842094A Anti-fatigue agent comprising amino acid composition |
| 09/22/2010 | CN101838337A Fructan consisting of 25 fructoses and 1 glucose |
| 09/22/2010 | CN101838309A Solid-phase synthesis of momordica charantia MC-JJ0102 polypeptide analogue under microwave irradiation and application thereof |
| 09/22/2010 | CN101838239A Pyrazole compound as well as composition and application thereof |
| 09/22/2010 | CN101837104A Fat optimizing capsules |
| 09/22/2010 | CN101837091A Process for continuously extracting polygonatum saponin and polygonatum polysaccharose |
| 09/22/2010 | CN101837063A Lipid-lowering and weight-reducing buccal tablets |
| 09/22/2010 | CN101837062A Lipid-lowering buccal tablets |
| 09/22/2010 | CN101837060A Chinese medicine for adjusting hypertension, hyperlipidemia and hyperglycemia |
| 09/22/2010 | CN101837059A Method for preparing apple polyphenol |
| 09/22/2010 | CN101837057A Components of compound formula of Chinese medicament active parts, preparation process thereof and anti-diabetic use thereof |
| 09/22/2010 | CN101837052A Herba saussureae involucratae medicinal granules and preparation method thereof |
| 09/22/2010 | CN101837040A Honeysuckle effective part, preparation process and anti-diabetic application |
| 09/22/2010 | CN101837032A Blueberry anthocyanin oral solution |
| 09/22/2010 | CN101837011A Medicinal composition for treating diabetes |
| 09/22/2010 | CN101837009A 一种亚硒酸钠维生素注射液及其制备方法 One kind of sodium selenite vitamin injection and preparation method |
| 09/22/2010 | CN101836987A Compound niacin sustained release tablet |
| 09/22/2010 | CN101836975A Application of isopentene group flavonoid compound used as pancreatic lipase inhibitor |
| 09/22/2010 | CN101836969A Dry ice defatting pill |
| 09/22/2010 | CN101836966A Agomelatine-containing orally disintegrating tablet |
| 09/22/2010 | CN101836956A Preparation process of fat emulsion injection products and fat emulsion injection products |
| 09/22/2010 | CN101836948A Nitro-brate-containing sustained-release solid preparation |
| 09/22/2010 | CN101836810A Blood-pressure-reducing pillow |
| 09/22/2010 | CN101066299B Extracting process and product of tartary buckwheat extract with rich tartary buckwheat flavone |
| 09/22/2010 | CN101066151B Beverage for diabetics and its prepn process |
| 09/22/2010 | CN101057677B Xinxi nutrient supplement |
| 09/21/2010 | US7799833 System and method for the pretreatment of the endplates of an intervertebral disc |
| 09/21/2010 | US7799827 zearalenone-like macrolides, used to to inhibit nuclear factor kappa-beta (NF- kappa B) activation, as sucnscreen agents and in the treatment of inflammatory or autoimmune disorders and disorders involving malignancy or increased angiogenesis |
| 09/21/2010 | US7799801 Heterocyclic aromatic compounds useful as growth hormone secretagogues |
| 09/21/2010 | US7799787 pyridazine derivatives such as N-(2-Cyclopropylethyl)-6-{4-[2-(trifluoromethyl)phenoxy]piperidin-1-yl}pyridazine-3-carboxamide, useful for the prevention and treatment of dyslipidemia, obesity, diabetes, syndrome X, insulin resistance, fatty liver, cancer, cardiovascular and nervous system disorders |
| 09/21/2010 | US7799785 such as (4aS,13bR,14aR)-6-fluoro-1,4a,9,13b,14,14a-hexahydrodibenzo[3',4':6',7']-cyclohepta[1',2':4,5]pyrrolo[1,2-c]imidazole-3(2H)-thione, having binding affinities towards serotonin receptors, dopamine receptors and with norepinephrine reuptake inhibition properties; antidepressants; neuroleptic agents |
| 09/21/2010 | US7799775 Pyrimidine derivatives |
| 09/21/2010 | US7799774 Quinoline derivatives and their use as 5-HT6 ligands |
| 09/21/2010 | US7799759 albumin fusion proteins. Nucleic acid molecules encoding the albumin fusion proteins of the invention are also encompassed by the invention, as are vectors containing these nucleic acids, host cells transformed with these nucleic acids vectors, and methods of making the albumin fusion proteins |
| 09/21/2010 | US7799351 Metal compounds, mixed or sulphated, as phosphate binders |
| 09/21/2010 | CA2449521C Pharmaceutical formulation, its use, and method for its manufacture |
| 09/21/2010 | CA2440559C Novel non-imidazole compounds |
| 09/21/2010 | CA2438593C Glucopyranosyloxypyrazole derivatives and medicinal use thereof |